SwissChems has been operating since 2018 and maintains a public test results page with 43 Janoshik-issued results. The catalog coverage on that page is partial - SARMs testing is more comprehensive than peptide-specific coverage, which creates an uneven picture across the full product range. The "Swiss" branding reflects an aesthetic choice rather than a geographic one; the operation is US-based. Score reflects a vendor with a meaningful operational history and a public testing record that stops short of full-catalog per-batch coverage.
| Dimension | Max | Notes | Score |
|---|---|---|---|
| Third-Party Testing Practice | 30 | Independent test results page publicly confirms Janoshik as the testing lab for published results. HPLC and mass spectrometry confirmed as methods. Terms confirm per-batch COA and lot-specific COA available on request. However, the 43 published results cover a fraction of the full catalog, testing coverage for peptides specifically is noted as less consistent than for SARMs by independent reviewers, and as of May 2026 SwissChems does not appear in Janoshik's or Finnrick's own public databases. | 18/30 |
| Batch Traceability & Verification | 20 | Terms confirm lot-specific COA available on request, tested by validated methods. A product authentication code is described on packaging. The independent test results page shows dated results per product. No QR-to-lab system. Lot-matched documentation exists but requires request rather than appearing in a searchable buyer-facing database. | 12/20 |
| COA Accessibility | 15 | Public independent test results page with 43 downloadable PDFs filterable by category and sortable by date. This is meaningfully more accessible than email-on-request. However, COAs are not consistently linked from individual product pages, and the page covers less than the full catalog. Access tier: public browseable page, partial catalog coverage. | 10/15 |
| COA Completeness | 15 | Published COA thumbnails show Janoshik-format reports with HPLC data. Methods described publicly as HPLC and MS. Endotoxin and sterility not confirmed in published documentation. Some independent reviewers note the specific testing lab is not always named on individual COA documents despite Janoshik being the described lab. | 10/15 |
| Testing Recency | 10 | Independent test results page shows dated reports, with the most recent visible entries from June 2026. Page was updated July 2026 per metadata. Recency evidence is present for published results. | 8/10 |
| Policy Transparency | 5 | Refund and return policy published at dedicated URL. Quality claim process described in terms with 30-day window and required documentation (lab report, chromatograms, lab contact details). Specific and detailed on the quality claim process. Minor deduction for no-refund on certain categories. | 4/5 |
| Operational Track Record | 5 | Founded 2018. US-based operation (New York address on FDA warning letter; company name notwithstanding). Domain registered through 2029. One of the longer-running gray market operations. Consistent catalog and active site maintenance. | 4/5 |
| Total | 66/100 |